Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Diabetes
Interventions
BIOLOGICAL

Wosulin R

Total dose per subject will be 0.3 IU/Kg given IV over 5 hrs.

BIOLOGICAL

Actrapid

Total dose per subject will be 0.3 IU/Kg given IV over 5 hrs.

Trial Locations (1)

91911

Profil Institute for Clinical Research Inc., Chula Vista

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Wockhardt

INDUSTRY